LOW-DENSITY-LIPOPROTEIN UPTAKE BY MACROPHAGES IN MULTIPLE-SCLEROSIS PLAQUES - IMPLICATIONS FOR PATHOGENESIS

Citation
J. Newcombe et al., LOW-DENSITY-LIPOPROTEIN UPTAKE BY MACROPHAGES IN MULTIPLE-SCLEROSIS PLAQUES - IMPLICATIONS FOR PATHOGENESIS, Neuropathology and applied neurobiology, 20(2), 1994, pp. 152-162
Citations number
25
Categorie Soggetti
Neurosciences,Pathology
ISSN journal
03051846
Volume
20
Issue
2
Year of publication
1994
Pages
152 - 162
Database
ISI
SICI code
0305-1846(1994)20:2<152:LUBMIM>2.0.ZU;2-Z
Abstract
Low density lipoprotein (LDL), the major carrier of plasma cholesterol , may enter the parenchyma of early multiple sclerosis (MS) lesions as a result of blood-brain barrier damage. We have used antibodies again st LDL and epitopes found in LDL oxidized by two peroxidative end-prod ucts, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), to immunocyt ochemically stain MS plaques at different stages of pathology. Native LDL, epitopes of MDA-LDL, peptides of myelin basic protein and neutral lipid oil red O (ORO) staining were found to be co-localized within f oamy macrophages in early and actively demyelinating MS plaques. Thus cholesterol esters, which are seen as Maltese crosses under polarized light in a proportion of foamy macrophages, appear to be derived from both LDL and myelin. ORO-negative astrocytes were strongly stained wit h the antibodies against 4-HNE-LDL and MDA-LDL, suggesting uptake of o xidatively modified protein products alone. Our findings suggest that a large proportion of the plasma LDL which enters the parenchyma of MS plaques is oxidatively modified in the lesion. Lipid peroxidation and oxidized LDL uptake by activated microglia and infiltrating macrophag es in the early stages of MS plaque development may play important rol es in demyelination.